Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Satsuma Pharmaceuticals stock

Learn how to easily invest in Satsuma Pharmaceuticals stock.

Satsuma Pharmaceuticals Inc is a biotechnology business based in the US. Satsuma Pharmaceuticals shares (STSA) are listed on the NASDAQ and all prices are listed in US Dollars. Satsuma Pharmaceuticals employs 24 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Satsuma Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – STSA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Satsuma Pharmaceuticals stock price (NASDAQ: STSA)

Use our graph to track the performance of STSA stocks over time.

Satsuma Pharmaceuticals shares at a glance

Information last updated 2022-07-01.
Latest market close$4.32
52-week range$2.51 - $7.46
50-day moving average $3.44
200-day moving average $4.40
Wall St. target price$11.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.78

Buy Satsuma Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Satsuma Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Satsuma Pharmaceuticals price performance over time

Historical closes compared with the close of $4.32 from 2022-07-01

1 week (2022-06-24) 20.00%
1 month (2022-06-03) 24.86%
3 months (2022-03-30) 13.09%
6 months (2022-01-03) -6.70%
1 year (2021-07-02) -39.75%
2 years (2020-07-02) -84.15%
3 years (2019-06-29) N/A
5 years (2017-06-29) N/A

Satsuma Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -29.58%
Return on equity TTM -49.96%
Profit margin 0%
Book value $2.76
Market capitalisation $136.3 million

TTM: trailing 12 months

Satsuma Pharmaceuticals share dividends

We're not expecting Satsuma Pharmaceuticals to pay a dividend over the next 12 months.

Satsuma Pharmaceuticals share price volatility

Over the last 12 months, Satsuma Pharmaceuticals's shares have ranged in value from as little as $2.51 up to $7.46. A popular way to gauge a stock's volatility is its "beta".

STSA.US volatility(beta: 1.04)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Satsuma Pharmaceuticals's is 1.0431. This would suggest that Satsuma Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Satsuma Pharmaceuticals overview

Satsuma Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. .

Frequently asked questions

What percentage of Satsuma Pharmaceuticals is owned by insiders or institutions?
Currently 10.373% of Satsuma Pharmaceuticals shares are held by insiders and 73.494% by institutions.
How many people work for Satsuma Pharmaceuticals?
Latest data suggests 24 work at Satsuma Pharmaceuticals.
When does the fiscal year end for Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals's fiscal year ends in December.
Where is Satsuma Pharmaceuticals based?
Satsuma Pharmaceuticals's address is: 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
What is Satsuma Pharmaceuticals's ISIN number?
Satsuma Pharmaceuticals's international securities identification number is: US80405P1075
What is Satsuma Pharmaceuticals's CUSIP number?
Satsuma Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 80405P107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site